Features of the course of non-alcoholic fatty liver disease in women at different age periods: literature review
И. А. Булатова,
No information about this author
Т. P. Shevlyukovа
No information about this author
Meditsinskiy sovet = Medical Council,
Journal Year:
2024,
Volume and Issue:
8, P. 90 - 95
Published: June 9, 2024
The
review
examines
the
epidemiology
and
risk
factors
of
non-alcoholic
fatty
liver
disease
(NAFLD)
for
women.
According
to
various
sources,
global
prevalence
NAFLD
ranges
from
20
40%
adult
population
in
world.
In
Russia,
37.3%
polyclinic
patients
have
NAFLD.
can
occur
at
any
age
has
differences
severity
depending
on
ethnicity
gender.
Over
past
10
years,
there
been
a
trend
towards
an
increase
among
women,
as
well
sharper
mortality
compared
men.
Regardless
gender,
prognostically
significant
include
age,
obesity,
type
2
diabetes
mellitus,
insulin
resistance,
dyslipidemia.
clinical
course
prognosis
women
depends
reproductive
stage
use
synthetic
hormones.
Premenopausal
less
pronounced
fibrosis
better
life
postmenopausal
men
article
describes
features
period,
pre-
characterizes
effect
steatosis
outcome
pregnancy,
perinatal
condition
mother
fetus.
Thus,
are
gender
prevalence,
factors,
fibrosis,
outcomes
is
higher
men,
but
after
menopause,
this
pathology
especially
those
with
metabolic
disorders.
Liver
affect
labor
postpartum
periods.
Language: Английский
Dynamics of the functional state of the liver and endothelium in patients with metabolic syndrome on the background of menopausal hormone therapy
И. А. Булатова,
No information about this author
Т. P. Shevlyukovа,
No information about this author
A. A. Sobol
No information about this author
et al.
Experimental and Clinical Gastroenterology,
Journal Year:
2024,
Volume and Issue:
3, P. 50 - 56
Published: March 19, 2024
The
aim.
To
evaluate
the
dynamics
of
metabolic
status,
functional
state
liver
and
endothelium
in
patients
with
syndrome
on
background
menopausal
hormone
therapy
(MGT).
Materials
methods.
40
women
were
examined,
which
25
an
average
age
51.2
±
1.2
years
15
practically
healthy
50.2
1.9
years.
anamnesis
was
collected,
presence
vasomotor
symptoms
assessed,
anthropometric
data
measured
calculation
body
mass
index,
laboratory
examination,
including
determination
blood
levels
sex
hormones,
tests,
parameters
markers
endothelial
dysfunction-
endothelin-1,
vascular
growth
factor,
number
desquamated
endotheliocytes
activity
Willebrand
instrumental
ultrasound
examination
assessment
response
to
local
heating
Microtest
device
(Russia),
as
well
Hepatic
steatosis
index
(HSI).
Results.
In
menopause,
symptoms,
complaints
dysuria,
dyspeptic
phenomena
observed,
increase
pressure
recorded
60%,
Kurlov’s
ordinates
24%,
36%
overweight,
64%
obese
1-2
degrees.
According
ultrasound,
verified
76%
patients,
HSI
>36.0
all
MS.
Against
estrogen
deficiency,
course
menopause
accompanied
by
insulin
resistance,
dyslipidemia,
increased
alkaline
phosphatase
28%
individuals
dysfunction
impaired
physiological
heating,
tone,
thrombogenic
potential
wall
activation
angiogenesis
mechanisms.
Conclusion:
MGT
Femoston
®
1
continuous
mode
reduces
severity
syndrome,
resistance
steatosis,
improves
characteristics
endothelium,
risk
cardiovascular
events
this
group.
Language: Английский